Table 2.
Crude and age-standardized percent prevalencea and 95% CI of overweight/obesity (BMI ≥25 kg/m2) and obesity (BMI ≥30 kg/m2), overall and by country − The TackSHS survey, 2017–2018
| Country | Sample characteristics | Prevalence (%) of overweight/obesity (95% CI) | Prevalence (%) of obesity (95% CI) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| age range, years |
mean age, years |
N c | men | women | men | women | ||||||
| men | women | crude | age-standardized | crude | age-standardized | crude | age-standardized | crude | age-standardized | |||
| Allb | ≥18 | 47 | 5,163 | 5,647 | 54.1 (52.8–55.5) | 53.8 (52.4–55.2) | 42.5 (41.2–43.8) | 43.0 (41.7–44.3) | 11.3 (10.5–12.2) | 11.2 (10.3–12.1) | 13.8 (12.9–14.7) | 13.8 (12.9–14.7) |
| Bulgaria | ≥18 | 49 | 476 | 524 | 63.9 (59.6–68.2) | 61.3 (56.9–65.7) | 50.4 (46.2–54.7) | 46.9 (42.6–51.2) | 21.3 (17.7–25.0) | 20.1 (16.5–23.7) | 17.9 (14.6–21.2) | 16.6 (13.4–19.8) |
| England | ≥18 | 43 | 437 | 545 | 50.6 (45.9–55.3) | 51.5 (46.8–56.2) | 47.3 (43.2–51.5) | 46.8 (42.6–51.0) | 15.1 (11.8–18.5) | 14.3 (11.0–17.6) | 22.2 (18.7–25.7) | 22.6 (19.1–26.1) |
| France | ≥18 | 47 | 460 | 508 | 39.6 (35.1–44.0) | 40.4 (35.9–44.9) | 35.2 (31.1–39.4) | 36.0 (31.8–40.2) | 8.0 (5.6–10.5) | 8.3 (5.8–10.8) | 9.5 (6.9–12.0) | 10.1 (7.5–12.7) |
| Germany | ≥18 | 50 | 426 | 448 | 65.4 (61.0–69.8) | 64.3 (59.8–68.8) | 40.8 (36.1–45.6) | 38.6 (34.1–43.1) | 9.3 (6.6–12.0) | 9.0 (6.3–11.7) | 8.7 (5.9–11.4) | 8.4 (5.8–11.0) |
| Greece | 18–64 | 41 | 454 | 438 | 62.6 (58.1–67.0) | 51.9 (47.3–56.5) | 42.7 (38.1–47.3) | 36.1 (31.6–40.6) | 19.2 (15.5–22.8) | 16.8 (13.4–20.2) | 20.3 (16.6–24.1) | 17.2 (13.7–20.7) |
| Ireland | ≥18 | 46 | 347 | 343 | 62.2 (57.0–67.4) | 62.4 (57.3–67.5) | 43.8 (38.5–49.2) | 44.3 (39.0–49.6) | 21.1 (16.7–25.5) | 21.4 (17.1–25.7) | 15.6 (11.7–19.5) | 15.8 (11.9–19.7) |
| Italy | ≥18 | 50 | 482 | 513 | 50.1 (45.6–54.5) | 47.9 (43.4–52.4) | 38.4 (34.3–42.5) | 37.0 (32.8–41.2) | 6.8 (4.6–9.1) | 6.4 (4.2–8.6) | 8.1 (5.8–10.4) | 7.7 (5.4–10.0) |
| Latvia | 18–74 | 46 | 454 | 433 | 62.2 (57.6–66.8) | 61.7 (57.2–66.2) | 53.0 (48.5–57.5) | 56.3 (51.6–61.0) | 17.2 (13.5–20.8) | 16.8 (13.4–20.2) | 21.0 (17.3–24.7) | 21.7 (17.8–25.6) |
| Poland | ≥18 | 45 | 268 | 384 | 52.4 (46.9–58.0) | 52.5 (46.5–58.5) | 42.2 (36.9–47.5) | 45.6 (40.6–50.6) | 11.0 (7.6–14.5) | 11.9 (8.0–15.8) | 16.6 (12.6–20.6) | 18.0 (14.2–21.8) |
| Portugal | ≥18 | 49 | 450 | 507 | 47.3 (42.7–52.0) | 46.0 (41.4–50.6) | 39.6 (35.4–43.9) | 40.5 (36.2–44.8) | 9.6 (6.8–12.3) | 9.4 (6.7–12.1) | 14.4 (11.3–17.5) | 14.2 (11.2–17.2) |
| Romania | ≥18 | 48 | 439 | 517 | 66.4 (62.1–70.7) | 63.4 (58.9–67.9) | 51.4 (47.0–55.9) | 50.3 (46.0–54.6) | 21.1 (17.4–24.8) | 20.1 (16.4–23.8) | 21.0 (17.4–24.7) | 20.1 (16.6–23.6) |
| Spain | ≥18 | 48 | 470 | 487 | 57.2 (52.7–61.7) | 56.5 (52.0–61.0) | 50.5 (46.1–55.0) | 50.8 (46.4–55.2) | 13.3 (10.2–16.4) | 13.1 (10.0–16.2) | 16.8 (13.4–20.1) | 17.1 (13.8–20.4) |
a Estimates are standardized by age, using the direct method with the population of the EU-28 as the reference population. b Prevalence estimates for the overall population were computed weighting each country in proportion to the country-specific adult population.c Raw numbers.